CLAUSEN PETER has filed 5 insider transactions across 1 company since August 2018.
Most recent transaction: a option exercise of 183853 shares of Nuo Therapeutics, Inc. ($AURX) on July 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 31, 2025 | Nuo Therapeutics, Inc. | $AURX | CLAUSEN PETER | CSO/COO | M | Common Stock | 183853 | $0.40 | 773,528.0000 | 46,816,114 | 31.18% | 0.39% |
| Aug. 9, 2018 | Nuo Therapeutics, Inc. | $AURX | CLAUSEN PETER | CSO/COO | M | Option to purchase common stock | 183853 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 20, 2024 | Nuo Therapeutics, Inc. | $AURX | CLAUSEN PETER | CSO/COO | A | Common Stock | 15000 | $0.75 | 589,675.0000 | 0 | 2.61% | 0.00% |
| Dec. 19, 2023 | Nuo Therapeutics, Inc. | $AURX | CLAUSEN PETER | CSO/COO | A | Common Stock | 20000 | $0.50 | 574,948.0000 | 0 | 3.60% | 0.00% |
| Aug. 1, 2023 | Nuo Therapeutics, Inc. | $AURX | CLAUSEN PETER | CSO/COO | A | Common Stock | 25000 | $2.00 | 554,948.0000 | 0 | 4.72% | 0.00% |